365 related articles for article (PubMed ID: 35854240)
21. Systematic Construction and Validation of an RNA-Binding Protein-Associated Prognostic Model for Acute Myeloid Leukemia.
Luo H; Zhang Y; Hu N; He Y; He C
Front Genet; 2021; 12():715840. PubMed ID: 34630514
[No Abstract] [Full Text] [Related]
22. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression.
Zhang J; Peng Y; He Y; Xiao Y; Wang Q; Zhao Y; Zhang T; Wu C; Xie Y; Zhou J; Yu W; Lu D; Bai H; Chen T; Guo P; Zhang Q
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166268. PubMed ID: 34536536
[TBL] [Abstract][Full Text] [Related]
23. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
24. A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia.
Deng C; Zeng T; Zhu P; Zhao S; Huang Z; Huang W; Zhang W; Huang X; Fu L
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10015-10025. PubMed ID: 37258721
[TBL] [Abstract][Full Text] [Related]
25. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia.
Li D; Wu X; Cheng C; Liang J; Liang Y; Li H; Guo X; Li R; Zhang W; Song W
Front Immunol; 2023; 14():1290968. PubMed ID: 38022627
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes.
Zhang Y; Ma S; Wang M; Shi W; Hu Y
Front Oncol; 2020; 10():578933. PubMed ID: 33117716
[No Abstract] [Full Text] [Related]
27. Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma.
Ou C; Liu L; Wang J; Dai S; Qu Y; Xiong Y; Xi W; Xu J; Guo J
Urol Oncol; 2017 Oct; 35(10):607.e1-607.e8. PubMed ID: 28619634
[TBL] [Abstract][Full Text] [Related]
28. A hypoxia-related genes prognostic risk model, and mechanisms of hypoxia contributing to poor prognosis through immune microenvironment and drug resistance in acute myeloid leukemia.
Liu X; Wang L; Kang Q; Feng C; Wang J
Front Pharmacol; 2024; 15():1339465. PubMed ID: 38482057
[No Abstract] [Full Text] [Related]
29. A Novel Identified Necroptosis-Related Risk Signature for Prognosis Prediction and Immune Infiltration Indication in Acute Myeloid Leukemia Patients.
Sun Y; Wang R; Xie S; Wang Y; Liu H
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292722
[TBL] [Abstract][Full Text] [Related]
30. T cell-mediated tumor killing sensitivity gene signature-based prognostic score for acute myeloid leukemia.
Pan Y; Xie F; Zeng W; Chen H; Chen Z; Xu D; Chen Y
Discov Oncol; 2024 Apr; 15(1):121. PubMed ID: 38619693
[TBL] [Abstract][Full Text] [Related]
31. NET-related gene signature for predicting AML prognosis.
Wang J; Wang H; Ding Y; Jiao X; Zhu J; Zhai Z
Sci Rep; 2024 Apr; 14(1):9115. PubMed ID: 38643300
[TBL] [Abstract][Full Text] [Related]
32. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia.
Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N
Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573
[TBL] [Abstract][Full Text] [Related]
33. The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
J Transl Med; 2021 May; 19(1):228. PubMed ID: 34051812
[TBL] [Abstract][Full Text] [Related]
34. Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia.
Wei J; Nai GY; Dai Y; Huang XJ; Xiong MY; Yao XY; Huang ZN; Li SN; Zhou WJ; Huang Y; Cheng P; Deng DH
Ann Transl Med; 2021 Sep; 9(17):1381. PubMed ID: 34733933
[TBL] [Abstract][Full Text] [Related]
35. Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes.
Wang Y; Bin T; Tang J; Xu XJ; Lin C; Lu B; Sun TT
Front Immunol; 2023; 14():1268090. PubMed ID: 38077322
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive analysis of nucleotide excision repair characteristics defines a novel prognostic signature for acute myeloid leukemia.
Bu XX; Cong J; Ling L; Lu BB; Wu CY; Jiang F; Wang ZM; Chen J
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):6917-6930. PubMed ID: 37606102
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.
Zhao Y; Zhang Y; Lu W; Sun R; Guo R; Cao X; Liu X; Lyu C; Zhao M
BMC Med Genomics; 2023 Nov; 16(1):296. PubMed ID: 37980495
[TBL] [Abstract][Full Text] [Related]
38. A novel immune prognostic model of non-M3 acute myeloid leukemia.
Ding H; Feng Y; Xu J; Lin Z; Huang J; Wang F; Luo H; Gao Y; Zhai X; Wang X; Zhang L; Niu T; Zheng Y
Am J Transl Res; 2022; 14(8):5308-5325. PubMed ID: 36105048
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of an eighteen-genes panel in acute myeloid leukemia by analyzing TARGET and TCGA databases.
Chen P; Cao J; Chen L; Gao G; Xu Y; Jia P; Li Y; Li Y; Du J; Zhang S; Zhang J
Cancer Biomark; 2023; 36(4):287-298. PubMed ID: 36938728
[TBL] [Abstract][Full Text] [Related]
40. Integration of CD34
Li XP; Zhang WN; Mao JY; Zhao BT; Jiang L; Gao Y
J Transl Med; 2022 Aug; 20(1):359. PubMed ID: 35962395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
